findmyKOL
Clinical trialNCT07316270RecruitingInterventional

SAfety and eFfectiveness of cathetER Ablation for Atrial Fibrillation With Intracranial Hemorrhage (SAFER-AF)

SponsorBeijing Anzhen HospitalEnrollment646AF - Atrial FibrillationIntracranial Hemorrhage, Spontaneous
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

SAFER-AF is an investigator-initiated, multicenter, open-label, parallel-group trial comparing catheter ablation versus usual care in patients with atrial fibrillation and intracranial hemorrhage.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

China
  • the First Affiliated Hospital of Anhui Medical University

    Hefei, Anhui, China

    Ronghui Yu, MD
    Not, yet, recruiting
  • Beijing Anzhen Hospital, Capital Medical University

    Beijing, Beijing Municipality, China

    Caihua Sang, MDChangsheng Ma, MD
    Recruiting
  • Xiamen Cadiovascular Hospital

    Xiamen, Fujian, China

    Yan Wang, MD
    Recruiting
  • the First Affiliated Hospital of Harbin Medical University

    Harbin, Heilongjiang, China

    Yue Li, MD
    Not, yet, recruiting
  • the Second Affiliated Hospital of Harbin Medical University

    Harbin, Heilongjiang, China

    Bo Yu, MD
    Not, yet, recruiting
  • the First Hospital of Jilin University

    Changchun, Jilin, China

    Qian Tong, MD
    Not, yet, recruiting
  • the First Affiliated Hospital of Xi'An Jiaotong University

    Xi'an, Shaanxi, China

    Zuyi Yuan, MD
    Not, yet, recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Usual Care
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
6 May 2026
Primary completion
31 Jan 2030
Completion
31 Jan 2030
Last update posted
7 Aug 2026
Registered enrollment
646
Registry id
NCT07316270

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.